Global AI-based Surgical Robots Market Size By Type (Services, Instrument and Accessories), By Application (General Surgery, Urology), By Region, And Segment Forecasts, 2023 to 2032

The Global AI-based Surgical Robots Market was valued at USD 5.1 billion in 2023 and is anticipated to reach USD 15.3 billion by 2031, growing at a robust CAGR of 14.4% during the forecast period (2023–2031). This significant growth is fueled by the rising adoption of AI in healthcare, increased demand for minimally invasive surgeries, and the continuous advancement of robotic systems. AI-based surgical robots enhance surgical precision, reduce recovery time, and lower the risk of complications, making them increasingly indispensable in modern operating rooms.

Drivers:

1. Surge in Minimally Invasive Surgeries

Patients and healthcare providers alike are increasingly opting for minimally invasive procedures due to their reduced postoperative pain, shorter hospital stays, and faster recovery times. AI-integrated surgical robots provide superior control and visualization, which are pivotal in such procedures.

2. Advancements in AI and Machine Learning

Technological strides in machine learning, computer vision, and real-time data analytics are enhancing the capabilities of surgical robots, enabling them to adapt during procedures, improve surgical outcomes, and reduce human error.

3. Growing Geriatric Population and Chronic Diseases

The aging global population and increasing prevalence of chronic conditions such as cancer, cardiovascular diseases, and orthopedic disorders are amplifying the need for precise surgical interventions, which is boosting the demand for AI-powered robotic systems.

Restraints:

1. High Cost of Robotic Surgical Systems

AI-based surgical robots entail substantial initial investment and ongoing maintenance costs, which can deter adoption, particularly in developing and underfunded healthcare systems.

2. Regulatory and Ethical Concerns

Strict regulatory frameworks, ethical considerations regarding AI in surgery, and concerns about accountability in case of surgical failures are challenges to market expansion.

Opportunity:

1. Expansion into Emerging Markets

Rapid improvements in healthcare infrastructure in Asia-Pacific, Latin America, and the Middle East are opening new growth avenues for AI surgical robotics, supported by rising government investments and medical tourism.

2. Integration with IoT and Augmented Reality

The convergence of AI with other technologies such as IoT and AR is expected to transform robotic surgery further by offering real-time monitoring, advanced diagnostics, and improved training capabilities.

Market by System Type Insights:

Based on system type, the Robotic Systems segment dominated the market in 2023 due to its extensive deployment in operating theaters across high-income countries. These systems are embedded with AI algorithms that support complex surgical procedures with enhanced accuracy. The Services segment is expected to witness the fastest growth, driven by demand for software upgrades, technical support, and surgeon training services.

Market by End-use Insights:

The Hospitals segment accounted for the largest market share in 2023, thanks to the widespread adoption of advanced surgical technologies in tertiary care centers and their ability to invest in high-cost infrastructure. Meanwhile, Ambulatory Surgical Centers (ASCs) are projected to grow rapidly due to the shift toward outpatient surgeries and cost-efficient care delivery models.

Market by Regional Insights:

North America led the market in 2023, supported by the presence of key players, advanced healthcare systems, and favorable reimbursement policies. Asia-Pacific is poised to grow at the fastest pace over the forecast period due to rising healthcare expenditure, increased awareness of robotic surgeries, and a growing middle-class population demanding quality care.

Competitive Scenario:

Prominent players in the AI-based surgical robots market include Intuitive Surgical, Inc., Medtronic plc, Stryker Corporation, Johnson & Johnson (through its subsidiary Ethicon), Zimmer Biomet Holdings, Inc., CMR Surgical, Smith & Nephew plc, and Asensus Surgical. These companies are focusing on strategic partnerships, FDA approvals, AI software enhancements, and expansion into new geographies.

Key Market Developments:

2023: Intuitive Surgical received FDA clearance for its new AI-enhanced da Vinci robotic platform, featuring predictive analytics and voice-assisted control.

2024: Medtronic partnered with a leading AI startup to develop real-time decision-support tools for its Hugo robotic system.

2025: Stryker launched a cloud-connected surgical robot that integrates AR for orthopedic procedures, setting new standards in digital surgery.

Scope of Work – Global AI-based Surgical Robots Market

Report Metric Details

Market Size (2023) USD 5.1 billion

Projected Market Size (2031) USD 15.3 billion

CAGR (2023–2031) 14.4%

Market Segments By System Type, By End-use, By Region

Growth Drivers Rise in minimally invasive surgeries, advancements in AI, growing aging population

Opportunities Emerging markets, integration with IoT and AR

FAQs:

1) What is the current market size of the Global AI-based Surgical Robots Market?

The market was valued at USD 5.1 billion in 2023.

2) What is the major growth driver of the Global AI-based Surgical Robots Market?

The primary growth driver is the rising demand for minimally invasive surgeries supported by AI-enhanced precision.

3) Which is the largest region during the forecast period in the Global AI-based Surgical Robots Market?

North America is projected to remain the dominant region due to its advanced healthcare infrastructure and early adoption of robotic surgery.

4) Which segment accounted for the largest market share in the Global AI-based Surgical Robots Market?

The Hospitals segment accounted for the largest share in 2023.

5) Who are the key market players in the Global AI-based Surgical Robots Market?

Key players include Intuitive Surgical, Medtronic, Stryker, Johnson & Johnson, Zimmer Biomet, and CMR Surgical.